Rare condition made mom feel like she was "walking on a hot bed of Legos"
The procedure seemed to go smoothly, but in the weeks that followed, she began to feel debilitating pain. A second surgery found that a screw placed in her foot had been pressing on the head of one of her nerves. That screw was moved, and a nerve decompression was performed but the pain didn't stop.
"It would just turn black and blue, swell up really big, and I just was unable to put any weight on it," 41-year-old Meade said.
The pain upended everything. She left her job as a surgical assistant since she could no longer stand for long periods. She was unable to take part in family activities with her two young sons. Even light breezes could trigger the pain. Resting under a blanket was unbearable, making sleep difficult. Meade compared the sensation to "walking on a hot bed of Legos constantly, while getting stabbed with a pencil."
Meade spent months seeing different specialists. Finally, after nearly a year, a doctor suggested Meade might have something called chronic regional pain syndrome. It was the first time Meade had heard of it. It would take even longer before she could find a treatment that helped her pain.
What is chronic regional pain syndrome?
Chronic regional pain syndrome, or CRPS, is a chronic disorder with no cure, said Dr. Rohan Jotwani, an interventional pain specialist and anesthesiologist at NewYork-Presbyterian and Weill Cornell Medicine. Jotwani was not involved in Meade's care. CRPS can occur after surgery, like Meade's, or from other injuries to the nerve.
"For some patients, they'll have an injury to a nerve and it will get better with time. For some patients, that injury will actually develop into its own chronic pain disorder," Jotwani said.
Diagnosing the condition is difficult, Jotwani said. No test or scan can definitively identify it, and because it is a rare condition, many doctors may not be familiar with it, he added.
Physicians have to rely on clinical criteria. Telltale hallmarks for the condition are extreme levels of pain at the source, even when nothing should be causing it - like when a bedsheet causes pain, as Meade experienced. CRPS patients may also experience swelling, changes in temperature and skin color or texture changes. They may even begin to lose function in the affected area.
Diagnosing chronic regional pain syndrome is only the start, Jotwani said. Actually treating the condition requires a "multi-pronged approach" that can vary from person to person. Treatment typically starts with physical therapy. Patients may also take medication to decrease nerve signals in the area, so they feel less pain, or try interventional techniques like a nerve block. Meade tried multiple options, but nothing was improving her pain.
"Doing regular therapies was not working. I even heard, at 33, that I was getting older and that 'sometimes we just hurt more.' I thought that was comical," Meade said.
Treating chronic regional pain syndrome
In 2022, long after Meade's pain started, a doctor suggested she see physical therapist Dr. Anita Davis, who specializes in treating the condition and leads the comprehensive pain rehabilitation program at Brooks Rehabilitation in Florida. The pair worked to develop a physical therapy routine that would work for Meade.
"Before me, she had all of the traditional exercises ... and those things were just not possible with that much pain in her foot," Davis said. "As healthcare providers, we ask patients to rate the pain from zero to 10. These folks are typically going to be at the top of the scale, even on a good day. When I ask her to do something that's painful on top of her existing pain, it's just crazy to think about doing that."
They also worked on relaxation and emotional exercises to cope with the mental load of the constant pain.
"Pain management for Amber ... isn't just the physical aspects," Davis explained. "Anything that enhances relaxing the nervous system is valuable."
The protocol led to some improvements for Meade, but while CRPS patients can have "symptoms subside for a length of time," it is "a lifelong condition," Davis said.
"There's not a cure for it," Davis said.
Working towards a less painful future
Meade said she still feels pain and discomfort, and is at risk of flare-ups when the weather changes or if she steps the wrong way. In addition to working with Davis, she is taking medication and receiving ketamine infusions every few months. She said the combination of ketamine treatment and physical therapy allows her to "do a lot more than I have been able to." The effects of the infusion usually last around four weeks. Meade uses that period to work on strengthening her body.
"I try to make some headway in my physical health before that starts going down, because I know it's going to," Meade said. "The pain is a lot less when my physical health is better."
Meade said even without the effects of the infusions, she is dealing with less pain than before her diagnosis and treatment. She can focus on her day-to-day activities. She sleeps better and can walk on the beach, one of her favorite activities. She can't do too much running around with her kids, but she can play catch and help with homework most days. Meade said she hopes to improve her functionality and eventually go back to work and be more active, but for now, she is grateful for what she has gained.
"I want to try to get to that point where I have less and less flares, and get up to doing what everybody enjoys doing: Working, coming home, having something to work towards, going on vacations," Meade said. "Every time I have a good day, we work a little bit harder."
Arkansas officials reveal new details about Devil's Den murders of husband and wife
The A.I. Divide | America Unfiltered
Defense attorneys refuse new cases in Massachusetts, citing unfair pay
Solve the daily Crossword
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
CareDx Announces Appointment of Nathan Smith as Chief Financial Officer
BRISBANE, Calif., August 06, 2025--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the appointment of Nathan Smith to the role of Chief Financial Officer. Nathan will lead key financial and accounting initiatives that are a part of the Company's long-term strategic growth plan. Nathan brings more than 14 years of experience in the molecular diagnostics industry, including senior finance leadership roles at Myriad Genetics and recent CFO positions at Blackrock Neurotech and WIN Brands. "Nathan's deep financial expertise in molecular diagnostics is a great fit for CareDx," said John Hanna, CEO of CareDx. "His track record of operational excellence and experience in supporting diagnostics companies to scale efficiently will be invaluable as we enter our next phase." In conjunction with this appointment, the Company also announced that Abhishek Jain will be retiring from his role as Chief Financial Officer. Abhishek will continue to support CareDx in a consulting capacity to ensure a seamless transition. "On behalf of the Board and the entire CareDx team, I want to express my sincere gratitude to Abhishek for his outstanding leadership as CFO," said John Hanna. "Abhishek's disciplined financial management, stewardship through our CEO transition, and dedication to strengthening our finance function have positioned CareDx for continued success. We wish him all the best." About CareDx CareDx, Inc., headquartered in Brisbane, California, is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. For more information, visit Forward Looking Statements This press release includes forward-looking statements related to CareDx, Inc. These forward-looking statements are based upon information that is currently available to CareDx and its current expectations, speak only as of the date hereof, and are subject to risks and uncertainties that could cause actual results to differ materially from those projected, including general economic and market factors and other risks discussed in CareDx's filings with the SEC, including, but not limited to, the Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed by CareDx with the SEC on February 28, 2025, the Quarterly Report on Form 10-Q for the quarter ended March 31, 2025 filed by CareDx with the SEC on April 30, 2025, and other reports that CareDx has filed with the SEC. Any of these may cause CareDx's actual results, performance, or achievements to differ materially and adversely from those anticipated or implied by CareDx's forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements. CareDx expressly disclaims any obligation, except as required by law, or undertaking to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise. View source version on Contacts CareDx Media Contacts Natasha Moshirian Wagnernwagner@ Investor RelationsCaroline Cornerinvestor@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13 minutes ago
- Yahoo
Ontario, medical association near new compensation deal they say will help retain, recruit family doctors
The Ontario government and the Ontario Medical Association (OMA) say they're close to reaching a new compensation deal for doctors working in family health organizations, which is intended to draw more physicians to family medicine amid a provincial doctor shortage. Both parties say the proposed changes, which would impact roughly 6,500 family physicians, are intended to encourage more doctors to practice or remain in comprehensive family medicine. Negotiations are happening as more than two million Ontarians are without a family doctor. The new model, called FHO+, would allow doctors to bill for administrative tasks that are currently unpaid, on top of clinical tasks, according to the OMA. The Ontario College of Family Physicians says in an average week, doctors spend about 19 hours on administrative tasks, such as filling out forms, charting and reviewing test results. An OMA spokesperson said in an email that the new compensation model "recognizes family physicians are treating patients with increasingly complex conditions, which often require physicians to spend more time completing administrative tasks." "We believe allowing family physicians to bill for this larger administrative workload will attract and retain more of them in Ontario," Julia Costanzo said in the emailed statement. "Our hope is that this new model will enable more Ontarians to [be] able access a family doctor." WATCH | Breaking down Ontario's family doctor shortage: The FHO+ model will also end "negation," the OMA statement said, the practice of financially penalizing a family doctor when a patient of theirs who is part of a family health team goes to a walk-in clinic or an emergency department for non-emergency care. The proposed deal would update the current compensation model, which pays doctors working in the province's 615 family health organizations through capitation. While different doctors are compensated in different ways, most family doctors get an annual payment from the government for every patient on their roster, with payments adjusted for factors like age and patient complexity. Bachir Tazkarji, a family physician and medical director of the teaching unit at Summerville Family Health Team, says he thinks the new deal would make comprehensive family medicine a bigger draw for new doctors. "Physicians are staying away from comprehensive family medicine practice, because they have less compensation, where, if they're working in hospitals or O.R., for example, they get compensated for more of this work," he said, adding that about 15 to 35 per cent of his month is spent doing administrative work. "I would think this [deal] is going to be very attractive and helpful to physicians for a better quality of life, reducing burnout and improving the patient's care, improving the direct contact with patients," he said. Health Minister Sylvia Jones told reporters at an unrelated news conference Wednesday that she would not comment on the details of negotiations with OMA, but that talks have been generally positive. A spokesperson for the Ministry of Health said in an email that the "FHO+ model incentivizes enrolling new patients, promotes shifting procedures to clinics instead of emergency departments, and strengthens incentives for after-hours care to expand access." The proposed deal was sent to arbitration in June, with a ruling expected in the fall. OMA CEO Kimberly Moran says the deal is about 90 per cent agreed upon and would be in place in April 2026 if finalized. She told CBC Radio's Here and Now Wednesday that while it's important doctors are compensated for "the really large and alarming amount of clinical administration time that they're spending," the province also needs to support physicians with teams and artificial intelligence tools that will reduce the work in the first place. "They didn't go to medical school [to be] on their computer. They went to medical school because they like to treat patients," she said. The Ford government has promised to connect every Ontarian to a family doctor or primary care team by 2029.
Yahoo
13 minutes ago
- Yahoo
FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths
WASHINGTON (AP) — U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices recently linked to injuries and deaths. The Food and Drug Administration issued two alerts Wednesday about electrical problems tied to the company's heart-zapping defibrillator systems and a separate issue with a heart implant used to reduce stroke risk. The agency said the company's Endotak Reliance defibrillator wires can become calcified, leading to failures in delivering life-saving shocks to the heart, according to the FDA. Defibrillators are surgically placed in the upper chest, where they monitor irregular heartbeats and use electrical shocks to jolt the heart back to normal. As of July 24, Boston Scientific has reported 386 serious injuries and 16 deaths associated with this issue, the agency said. Ten of the deaths were judged to be due to the device failing to function properly, the company said in an email. Four were linked to attempts to surgically remove the devices from patients and two others were deemed unrelated to the implants. Boston Scientific's wires were distributed between 2002 and 2021 and are no longer available, the company noted in its letter to doctors. Some patients will need to have the devices replaced, though physicians should weigh the risks of the removal procedure. In a separate notice, the FDA said Boston Scientific recently updated instructions for implanting its Watchman device, which closes a portion of the heart's left atrium to reduce the risk of stroke. In a letter to physicians, the company noted that there is an increased risk of blockages in the bloodstream depending on the level of anesthesia for patients undergoing the initial implantation procedure. Watchman is an alternative to long-term treatment with blood thinners for patients at increased risk of stroke. As of July 30, the company has reported 120 serious injuries and 17 deaths related to the issue, the FDA said. A company investigation concluded that the safety issue 'is not associated with the design or manufacture of any component of the Watchman system. Heart devices, including defibrillators and other implants, are Boston Scientific's largest business, making up two-thirds of its $5 billion in revenue for the most recent quarter. Shares of Boston Scientific Corp. fell nearly 1.8 percent Wednesday to close at $102.95 in trading. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.